Skip to main content
. 2011 Oct 1;26(10):1277–1285. doi: 10.3346/jkms.2011.26.10.1277

Fig. 4.

Fig. 4

Comparison of the expression rates of biomarkers between carcinoma ex pleomorphic adenomas with luminal and non-luminal differentiations in malignant components. p53 and c-erbB-2 overexpression rates in CXPA-LD are significantly higher than those in CXPA-NLD. *Statistically significant (P ≤ 0.05)